Athena Countouriotis insider trades: Turning Point Therapeutics (TPTX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Athena reports to the SEC
and 2 more companies
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 9, 2022 | TPTX | ↓ Sell | 2,971 | $36.30 | $108K | Direct | Feb 11, 2022 (2d) |
| Feb 11, 2021 | TPTX | ↓ Sell | 60,000 | $137.48 | $8.2M | Direct | Feb 11, 2021 (0d) |
| May 21, 2020 | TPTX | ↑ Buy | 4,166 | $60.00 | $250K | Direct | May 26, 2020 (5d) |
| Mar 24, 2020 | PASG | ↑ Buy | 10,000 | $14.97 | $150K | Direct | Mar 25, 2020 (1d) |
| Mar 3, 2020 | PASG | ↑ Buy | 8,900 | $18.00 | $160K | Direct | Mar 3, 2020 (0d) |
| Sep 10, 2019 | TPTX | ↑ Buy | 10,000 | $45.00 | $450K | Direct | Sep 11, 2019 (1d) |
| Apr 22, 2019 | TPTX | ↑ Buy | 12,000 | $18.00 | $216K | Direct | Apr 24, 2019 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Athena Countouriotis's insider trades
Athena Countouriotis is President & CEO at Turning Point Therapeutics (TPTX). Since Apr 22, 2019, Athena has reported 5 open-market purchases worth $1.2M and 2 sales worth $8.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (35 filings), option exercises (5 filings), shares withheld for taxes (4 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TPTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.